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Abstract The objective of this study is to investigate the
prevalence of Andersson lesions (AL) in ankylosing spondy-
litis (AS) patients who will start anti-tumor necrosis factor
(TNF) treatment. Radiographs and magnetic resonance
imaging (MRI) of the spine were performed before therapy
with anti-TNF. ALs were defined as discovertebral endplate
destructions onMRI, associated with bonemarrow edema and
fat replacement or sclerosis, a decreased signal on T1,
enhancement after contrast administration (gadolinium
diethylenetriamine pentaacetic acid (Gd-DTPA)), and
increased signal on T2 and short tau inversion recovery
(STIR). Additionally, conventional radiography showed a
fracture line, irregular endplates, and increased sclerosis
of adjacent vertebral bodies. Fifty-six AS patients were
included, 68% males, mean age of 43 years, and mean
disease duration of 11 years. The mean bath ankylosing
spondylitis disease activity index was 6.4, and 24% of all
patients had ankylosis. Only one patient showed a
discovertebral abnormality with bone marrow edema of
more than 50% of the vertebral bodies adjacent to the
intervertebral disk of T7/T8 and T9/T10, a hypodense
signal area on T1, and a high signal on STIR. Irregular
endplates were depicted, and T1 after Gd-DTPA demonstrated
high signal intensity around the disk margins. However, no
fracture line was visible on conventional radiology, and
therefore, this case was not considered to be an AL. No AL
was detected in our AS patients, who were candidates for anti-
TNF treatment. One patient showed a discovertebral abnor-
mality on MRI, without a fracture line on conventional
radiology. The relative small proportion of patients with a
long-established disease might explain this finding for,
particularly, an ankylosed spine is prone to develop an AL.
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Introduction
Ankylosing spondylitis (AS) is a chronic inflammatory
rheumatic disease that affects especially males in the second
and third decades of life, with a prevalence of 0.5–0.9% [1].
The main clinical symptom is inflammatory back pain
typically occurring at night and morning stiffness improving
after exercise. The pain, stiffness, and limited mobility of the
spine can cause severe limitations in daily life activities.
Inflammation in AS usually is localized in the sacroiliac
joints and the axial skeleton. The last decade there is an
increasing interest in the spinal involvement in AS visible
on magnetic resonance imaging (MRI) [2–5]. There is a
wide range of abnormalities described in the spine of AS
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patients. Apart from syndesmophytes and ankylosis of
the spine resulting in rigidity, in longstanding AS, also
focal destructive discovertebral lesions (Andersson lesion
(AL)) can occur, also known as ALs [6, 7]. In 1996,
Rasker et al. described six cases of spondylodiscitis in AS
[8].
Recently, we described a review on ALs, which show
disk space narrowing or widening, vertebral bone
destruction, a surrounding zone of sclerosis, and local
kyphosis at radiographs of the spine (Fig. 1) [7]. One of
the causes of an AL is the local inflammation in the spine
in combination with a minor trauma. This lesion can be
differentiated from the signs of inflammation at the MRI
of the spine of active disease in AS, as is often observed in
patients who are candidates for tumor necrosis factor
(TNF) blocking treatment. An AL might be difficult to
detect on clinical symptoms alone because most AS
patients suffer from back pain. More important is the fact
that an AL requires a different treatment, for instance
immobilization, in contrast with the physical therapy
normally prescribed in AS patients.
The aim of this study was to investigate whether in AS
patients, who are candidates for treatment with anti-TNF,
ALs could be detected.
Methods
Patients
AS patients were derived from the outpatient clinics of the VU
University Medical Center (Vumc) and the Jan van Breemen
Institute (JBI) in Amsterdam. All AS patients who fulfilled the
modified New York criteria and met the criteria for starting
treatment with TNF-blocking agents according to the interna-
tional ASAS consensus statement [9, 10] were included.
Following this ASAS statement, all patients had an
active disease as defined by a bath ankylosing spondylitis
disease activity index (BASDAI) of ≥4 (scale 0–10) [11],
had failed to previous therapy with at least two nonsteroidal
anti-inflammatory drugs and sulfasalazine in case of
peripheral arthritis, and should be treated with TNF-
blocking agents according to an expert. Patients were
enrolled consecutively, but mainly because of limited
availability of the MR scanner, several patients could not
be included. Furthermore, one patient did not fit into the
scanner due to severe kyphosis, and several patients
suffered from claustrophobia. At baseline, data that con-
form to daily clinical practice during treatment with TNF-
blocking agents were collected in all patients who gave
their written informed consent.
Radiology
Standing anteroposterior and lateral full-length plain films
and an MRI of the whole spine were performed before the
start of anti-TNF therapy. MRI were obtained at baseline
and after 6–24 months of anti-TNF therapy, using T1-
weighted spin-echo sequences (T1) before and after
administration of the contrast medium gadolinium dieth-
ylenetriamine pentaacetic acid (Gd-DTPA), T2-weighted
sequences (T2), and fat-suppression sequences (short tau
inversion recovery (STIR)). In patients included in the JBI,
MRI of the spine was performed in the Amstelland Hospital
Amstelveen with a field strength of 0.5 tesla, starting from
the third cervical vertebra (C3) and downwards. In patients
included in the Vumc, MRI of the whole spine was
performed with a field strength of 1.5 tesla. Pre- and post-
(Gd) T1 TSE and STIR MRIs were acquired. In the
Amstelland Hospital Amstelveen, T2 was acquired as well.
The conventional radiographs and MRI were read by
two observers, one orthopedic surgeon (BvR) and a
radiologist (RM), who were blinded to the status of the
subjects. The consensus score was accepted. First, the
conventional radiographs were analyzed followed by an
assessment of the MRI. The extent of spinal ankylosis in
the total study cohort was estimated by counting extensive
syndesmophyte formation or bamboo spine features on
conventional radiographs counted by segment.
Fig. 1 A lateral radiograph of the lumbar spine shows an Andersson
lesion with extensive bony destruction of the L1–L2 disk with
irregular endplates and increased sclerosis of adjacent vertebral bodies
(from Van Royen et al. with permission)
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The extent of abnormalities in the discovertebral unit
was compared with the same discovertebral unit in different
sagittal MR sequences and the other way around.
An AL was defined as an abnormality in the discov-
ertebral junction that shows on MRI diffuse endplate
destruction, with associated bone marrow edema and fat
replacement or sclerosis [12]. The fracture cleft through the
disk space or vertebra itself is depicted as decreased signal
on T1 and increased signal on T2, STIR, and T1 imaging
after Gd-DTPA administration, reflecting reactive edema of
the fracture. Conventional radiography of the AL must
show a fracture line, irregular endplates, and increased
sclerosis of adjacent vertebral bodies.
Statistical analysis
This concerns a descriptive study. Continuous variables
were reported as the mean ± SD or, if skewed, as the
median (range). Categorical variables were calculated as
frequencies and percentages.
Results
In total, 56 AS patients were included, 36 in the VUmc and
20 in the JBI, and the baseline characteristics of all patients
are summarized in Table 1. Patients from the two centers
did not differ in gender, age, or disease activity at baseline.
Radiographs at baseline were available in 55 of the total 56
patients. MRI was performed at baseline in all 56 patients.
In two patients, an alternative MRI procedure was
performed due to a severe kyphotic posture. These MR
scans were still suitable for the purpose of our study.
Radiology
Systematic examination of conventional radiographs of the
cervical, thoracic, and lumbar spine did not reveal any lesions
that met the definition of AL. Distinct ankylosis with extensive
syndesmophyte formation was seen in 13 of 55 (24%) of the
patients determined with conventional radiography of the
spine. Spinal ankylosis or bridging syndesmophytes over
multiple vertebrae were seen at the cervical, thoracic, and
lumbar segment in 16%, 6%, and 7% of patients, respectively.
Conventional radiographs and MRIs of the whole spine
showed no AL according to our definition. However, one
patient showed a discovertebral abnormality on MRI. This
abnormality showed bone marrow edema of more than 50%
of the vertebral bodies adjacent to the intervertebral disk of
T7/T8 and T9/T10 (Fig. 2), a hypodense signal area on T1
and high signal on STIR. Irregular endplates of the vertebra
at these levels were depicted on all sequences. T1 after
administration of Gd-DTPA demonstrated high signal
intensity around the disk margins of T7/T8 and T9/T10.
However, no fracture line was visible on conventional
radiology.
The clinical characteristics of this patient did not
differ from the other patients. He was a male, aged
65 years, with a BASDAI and CRP of 5 and 35 mg/L,
respectively, indicative of an active disease. He did not
report any specific localizing complaints or a preceding
(minor) trauma. He had suffered from complaints of low
back pain for 40 years and was diagnosed with AS at the
age of 51.
After 24 months treatment with infliximab, T1-
weighted images showed a decrease of signs of acute
inflammation such as bone marrow edema and maybe
even an increase of post-inflammatory fatty bone marrow
degeneration around the disk margins. The T1-weighted
post-contrast images demonstrated no high signal inten-
sity around the disk margins of T7/T8 and T9/T10
anymore. There were signs of progression of the
ankylosis and kyphosis in the thoracic segment after
2 years of follow-up despite anti-TNF treatment. Apart
from the focus on ALs, other abnormalities involving the
discovertebral unit as described in literature on MRI in
AS were encountered. Romanus lesions, which are acute
inflammatory lesions at the corners of the endplates of
Mean ± SD Range
Number 56
Age (in years) 43±10.8 22–73
Male gender (%) 38 68
Disease duration (in years)a 11±8.7 1–41
Symptom duration (in years)b 21±11.3 1–49
BASDAI (0–10)c 6.4±1.4 4.0–9.7
Tragus-to-wall distance (cm; normal, <15 cm) 16±6.0 11–44
Lumbar flexion index (cm; normal, >5 cm) 2.5±1.2 0.3–5
Lumbar side flexion (cm; normal, >10 cm) 10±4.9 3.8–19
Chest expansion (cm; normal, >5 cm) 3.4±1.5 0.5–7
Table 1 Baseline characteristics
a Disease duration: mean time be-
tween the diagnosis and baseline
b Symptom duration: mean time
between the first symptoms and
baseline
c BASDAI: bath ankylosing spon-
dylitis disease activity index; mean
value, 11
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the vertebra, were often detected. These lesions show
bone marrow edema in the corners of vertebral endplates
and are depicted as hypodense signal areas in T1- and
high signal in T2-weighted images [13].
Discussion
In 56 AS patients, who fulfilled the criteria for treatment
with TNF-blocking agents, only one lesion resembling an
AL of the thoracic spine was detected with MRI, but this
lesion lacked a fracture line on the conventional
radiograph.
The low prevalence of ALs was unexpected because this
group of AS patients had a relatively high rate of ankylosis
of the spine (24%) and signs of active inflammation. This
was in concordance with the moderate impairment of the
mobility of the spine in these patients. The mean tragus-to-
wall distance was 16 cm (normal, <15 cm), mean lumbar
flexion index was 2.5 cm (normal, >5 cm), the mean
lumbar side flexion was 10 cm (normal, >10 cm), and the
mean chest expansion was 3.4 (normal, >5 cm) [14]. The
percentage of ALs as described in literature in this subset of
severe AS patients varies between 1% and 28% [15–21].
Many studies report that the presence of an AL is
associated with long standing disease in AS and with a
rigid, ankylosed spine [22–24], concluding that an AL is a
late complication of AS [18]. The low prevalence of ALs in
our study was probably caused by the relatively short
disease duration, with a mean of 11 years and a mean age of
43 years. This could be due to a selection bias, for mostly
young patients with an active disease were referred for
treatment with TNF-blocking agents, whereas the efficacy
of TNF blockers in older and more severe cases of AS with
complete ankylosis of the spine was still doubtful at the
time of the study.
A severe kyphotic deformity and an osteoporotic spine
put a patient at risk of development of a stress fracture in
the ankylosed spine [25, 26]. Our study contains patients
with a severe, kyphotic, thoracic spine. However, we did
not find any features of stress fractures in this susceptible
subgroup of patients, probably due to the small group size.
Another cause of the low prevalence of ALs in this
study might be due to the radiographic techniques used
to detect them, although the combination of conventional
radiographs of the spine and MRI with gadolinium
should be sensitive enough. Hermann et al. compared
MRI and conventional radiography of spinal changes in
patients with spondyloarthritis [22]. They concluded that
the best way to detect syndesmophytes was through
radiography; ankylosis was detected equally well by both
radiography and MRI, but for all other lesions, MRI was
the preferred method. A disadvantage of conventional
radiographs of the spine is the difficult analysis of the
vertebrae of the thoracic segment because of the over-
imposed lung tissue [27], while most disorders of the
discovertebral junction occur in the lower part of the
thoracic and upper parts of the lumbar spine [28, 29]. MRI
is important for early detection of discovertebral lesions
and described as a sensitive method to detect ALs, in
particular, after administration of gadolinium [13]. Some
MRIs in our study showed features of severe degenerative
disk disease (DDD), specifically lumbar-sacral. The MRI
features of these degenerative abnormalities were some-
times difficult to distinguish from destructive discoverte-
bral lesions as was described by Jevtic et al., who showed
that the appearance of an AL can resemble Modic type III
degenerative lesion [13]. One point to differentiate
between AL and DDD in AS is the fact that an AL occurs
as a result of inflammation in combination with mechan-
ical stress of the ankylosed spine. Another point is that AL
differs from DDD in the localization, because most AL
Fig. 2 a T1-weighted gadolini-
um diethylenetriamine penta-
acetic acid postcontrast image
demonstrated high-signal inten-
sity around the disk margins of
T7–T8 and T9–T10. b T1-
weighted image shows low-
signal intensity bone marrow
edema in the adjacent vertebral
endplates of the T7/T8 and T9/
T10 disk spaces. c T1-weighted
image, obtained 24 months after
treatment with anti-tumor ne-
crosis factor agents
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lesions occur at the level of the cervical and thoracolum-
bar spine, whereas the DDD predominate at the lumbosa-
cral level [7].
The debate about the prevalence of ALs is hampered by
the lack of uniformity in the nomenclature of these lesions.
For example, the term AL has been employed for severe
destructive discovertebral lesions, but also for minor
abnormalities such as degenerative changes and local
inflammation around in the discovertebral junction, as
described in our case [7, 12].
To conclude, no ALs was detected by using conventional
radiographs and MRI in this study in 56 severe AS patients,
whereas a higher prevalence was described in literature.
The discrepancy might be due to the relatively small group
of patient with a short disease duration and young age
despite the severe ankylosed spine in our study cohort.
Despite the absence of ALs in our study, we would like
to increase the awareness of this complication in AS. In
case of a minor spine trauma, an MRI should be combined
with the conventional spine radiographs in order to detect
this lesion in the stiff and vulnerable spine, which is often
osteoporotic as well. The treatment of an AL lesion consists
of immobilization instead of the routinely advised exercise
program or even surgical decompression in case of
neurological deficits [7].
In previous studies, there has been no sequential MRI
study of the spine in patients with AS that visualizes the
evolution from an early discovertebral lesion, as described
in our patient, into a severe destructive discovertebral
lesion, by some authors called an AL. Thus, it remains
unclear whether and how often an abnormality in the
discovertebral junction develops into an AL. More research
with a long-term follow-up of discovertebral lesions is
necessary to clarify the evolution of these lesions.
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